Cargando…
The BCL2L11 deletion polymorphism is not associated with imatinib resistance in chronic myeloid leukemia patients: meta-analysis
A common deletion polymorphism of the gene Bcl-2 like protein 11 (BCL2L11, BIM) has been reported to cause tyrosine kinase inhibitors (TKIs) resistance in several malignant tumors. However, the conclusions were not consistent in chronic myeloid leukemia (CML) individuals. In order to obtain a reliab...
Autores principales: | Xu, Jinyun, Gu, Jiaowei, Zhao, Yan, Meng, Huihua, Du, Li’an, Zhang, Ruibo, Jiang, Hao, Luo, Jianming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716789/ https://www.ncbi.nlm.nih.gov/pubmed/29228749 http://dx.doi.org/10.18632/oncotarget.21154 |
Ejemplares similares
-
Association Between TP53 Gene Codon 72 Polymorphism and Acute Myeloid Leukemia Susceptibility: Evidence Based on a Meta-Analysis
por: Ruan, Xiao-Lan, et al.
Publicado: (2015) -
Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
por: He, Pin-Fang, et al.
Publicado: (2017) -
MicroRNA-181 as a prognostic biomarker for survival in acute myeloid leukemia: a meta-analysis
por: Guo, Qiang, et al.
Publicado: (2017) -
Correlations between MDM2 gene SNP309 Polymorphism and Susceptibility to Leukemia
por: Ou, Wen-Bin
Publicado: (2015) -
Ethnic differences in the association between angiotensin-converting enzyme gene insertion/deletion polymorphism and peripheral vascular disease: A meta-analysis
por: Han, Chao, et al.
Publicado: (2017)